Image of Christopher Gannatti

Christopher Gannatti, CFA

Global Head of Research


Christopher Gannatti began at WisdomTree as a Research Analyst in December 2010, working directly with Jeremy Schwartz, CFA®, Director of Research. In January of 2014, he was promoted to Associate Director of Research where he was responsible to lead different groups of analysts and strategists within the broader Research team at WisdomTree. In February of 2018, Christopher was promoted to Head of Research, Europe, where he was based out of WisdomTree’s London office and was responsible for the full WisdomTree research effort within the European market, as well as supporting the UCITs platform globally. In November 2021, Christopher was promoted to Global Head of Research, now responsible for numerous communications on investment strategy globally, particularly in the thematic equity space. Christopher came to WisdomTree from Lord Abbett, where he worked for four and a half years as a Regional Consultant. He received his MBA in Quantitative Finance, Accounting, and Economics from NYU’s Stern School of Business in 2010, and he received his bachelor’s degree from Colgate University in Economics in 2006. Christopher is a holder of the Chartered Financial Analyst Designation.

Latest Insights From Christopher Gannatti

At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In the third part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the evolution of AlphaFold 3. 
Read the article
We just passed the 20th of July, 2024, and approximately 90 days have passed since the pivotal bitcoin halving event in April. While Bitcoin flirted with all-time-high price levels earlier this year, nearing $74,000, Chris Gannatti and Blake Heimann explain why recent trends might refocus investors on the longer term.
Read the article
Nvidia isn’t the only player in the semiconductor field. Christopher Gannatti and Mobeen Tahir highlight other companies making significant strides in the semiconductor industry.
Read the article
The AI revolution is reshaping our world, and our strategies are evolving to keep pace. Christopher Gannatti analyzes our WisdomTree Artificial Intelligence & Innovation and U.S. Quality Growth Funds and provides insights into market dynamics and the influence of major AI players like Nvidia and the Magnificent 7.
Read the article
Late 2023 was a period of high hopes for interest rate cuts from the U.S. Federal Reserve. Christopher Gannatti discusses the resulting boom in SaaS stocks and their subsequent decline in the first half of 2024. 
Read the article
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In this second part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the journey to the mRNA vaccine.
Read the article
Actionable Ideas

As 2023 draws to a close, what will 2024 have in store for investors? It appears this Fed rate hike cycle is over and now we pivot to potential rate cuts. But not until inflation has sufficiently cooled. As we've seen before, a lot can happen in the meantime.

Read more
Marking to Market: 2024 Outlook

As 2023 draws to a close, what will 2024 have in store for investors? It appears this Fed rate hike cycle is over and now we pivot to potential rate cuts. But not until inflation has sufficiently cooled. As we've seen before, a lot can happen in the meantime.

Read more
Can We Westernize the Battery Supply Chain?
In a conversation from March 30, 2023, Christopher Gannatti, WisdomTree Global Head of Research, and Adam Woods, Senior Research Analyst, Global Coal Markets, for Wood Mackenzie, discuss the energy storage space as well as some of the intersections between these dynamics and the specific WisdomTree investment strategy.
Read more
Megatrends in 2024
Read more
Why WisdomTree Believes the BioRevolution Could Deliver Strongly in 2024
Read more
Breaking Down the Cybersecurity Megatrend
Read more
Invest in the Future with Artificial Intelligence
Read more
Webinar Replay: AI and the Markets
Read more
Beyond the Macro, To the Potential of the BioRevolution
Read more
As the Digital World Expands Massively, We Have to Secure It!
Read more
Nasdaq TradeTalks: The WisdomTree Cybersecurity Fund
Read more
BioRevolution: Hacking the Code of Life
Read more

WisdomTree does not receive compensation for the book recommendation.